BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27743074)

  • 1. Well-Differentiated, Non-Functional, Non-Ampullary Duodenal Neuroendocrine Tumors: Toward Defining Evaluation and Management.
    Weatherall T; Denbo J; Sharpe J; Martin M; O'Brien T; Gupta R; Groshart K; Behrman S; Dickson P
    World J Surg; 2017 Mar; 41(3):844-850. PubMed ID: 27743074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of neuroendocrine tumors in the second portion of the duodenum: a single center experience and systematic review of the literature.
    Iwasaki T; Nara S; Kishi Y; Esaki M; Shimada K; Hiraoka N
    Langenbecks Arch Surg; 2017 Sep; 402(6):925-933. PubMed ID: 27915372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for lymph node metastasis in duodenal neuroendocrine tumors: A retrospective, single-center study.
    Park SG; Lee BE; Kim GH; Park JW; Lee MW; Kim SJ; Choi CW; Lee S; Park DY
    Medicine (Baltimore); 2019 Jun; 98(23):e15885. PubMed ID: 31169696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
    Untch BR; Bonner KP; Roggin KK; Reidy-Lagunes D; Klimstra DS; Schattner MA; Fong Y; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Kingham TP; Tang LH
    J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.
    Tsolakis AV; Ragkousi A; Vujasinovic M; Kaltsas G; Daskalakis K
    World J Gastroenterol; 2019 Sep; 25(35):5376-5387. PubMed ID: 31558880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
    Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
    Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
    Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Multi-institutional Analysis of Duodenal Neuroendocrine Tumors: Tumor Biology Rather than Extent of Resection Dictates Prognosis.
    Margonis GA; Samaha M; Kim Y; Postlewait LM; Kunz P; Maithel S; Tran T; Berger N; Gamblin TC; Mullen MG; Bauer TW; Pawlik TM
    J Gastrointest Surg; 2016 Jun; 20(6):1098-105. PubMed ID: 27008594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risk Factors for Metastasis in Non-Ampullary Duodenal Neuroendocrine Tumors Measuring 20 mm or Less in Diameter.
    Hatta W; Koike T; Iijima K; Asanuma K; Asano N; Musha H; Inomata Y; Sano T; Endo H; Ikehata A; Horii T; Ohyauchi M; Yokosawa S; Kasajima A; Fujishima F; Sasano H; Nakaya N; Nakamura T; Shimosegawa T
    Digestion; 2017; 95(3):201-209. PubMed ID: 28315861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical resection for duodenal neuroendocrine neoplasia: Outcome, prognostic factors and risk of metastases.
    Nießen A; Bergmann F; Hinz U; Schimmack S; Hackert T; Büchler MW; Strobel O
    Eur J Surg Oncol; 2020 Jun; 46(6):1088-1096. PubMed ID: 32088004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?
    Gamboa AC; Liu Y; Lee RM; Zaidi MY; Staley CA; Kooby DA; Winer JH; Shah MM; Russell MC; Cardona K; Maithel SK
    J Surg Oncol; 2019 Dec; 120(8):1293-1301. PubMed ID: 31621090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified duodenal neuroendocrine tumor staging schema better defines the risk of lymph node metastasis and disease-free survival.
    Kachare SD; Liner KR; Vohra NA; Zervos EE; Fitzgerald TL
    Am Surg; 2014 Aug; 80(8):821-6. PubMed ID: 25105406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical outcomes of patients with duodenal vs pancreatic neuroendocrine tumors following pancreatoduodenectomy.
    Dong DH; Zhang XF; Lopez-Aguiar AG; Poultsides G; Rocha F; Weber S; Fields R; Idrees K; Cho C; Spolverato G; Maithel SK; Pawlik TM
    J Surg Oncol; 2020 Sep; 122(3):442-449. PubMed ID: 32470159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duodenal neuroendocrine tumors: Impact of tumor size and total number of lymph nodes examined.
    Zhang XF; Wu XN; Tsilimigras DI; Poultsides G; Rocha F; Abbott DE; Fields R; Idrees K; Cho C; Maithel SK; Pawlik TM;
    J Surg Oncol; 2019 Dec; 120(8):1302-1310. PubMed ID: 31680243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine Tumors (NETs) of the Minor Papilla/Ampulla: Analysis of 16 Cases Underlines Homology With Major Ampulla NETs and Differences From Extra-Ampullary Duodenal NETs.
    Vanoli A; Albarello L; Uncini S; Fassan M; Grillo F; Di Sabatino A; Martino M; Pasquali C; Milanetto AC; Falconi M; Partelli S; Doglioni C; Schiavo-Lena M; Brambilla T; Pietrabissa A; Sessa F; Capella C; Rindi G; La Rosa S; Solcia E; Paulli M
    Am J Surg Pathol; 2019 Jun; 43(6):725-736. PubMed ID: 30913089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable long-term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumor.
    Matsueda K; Kanesaka T; Kitamura M; Shichijo S; Maekawa A; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Michida T; Honma K; Miyashiro I; Ishihara R
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3329-3336. PubMed ID: 34142385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases.
    Vanoli A; La Rosa S; Klersy C; Grillo F; Albarello L; Inzani F; Maragliano R; Manca R; Luinetti O; Milione M; Doglioni C; Rindi G; Capella C; Solcia E
    Neuroendocrinology; 2017; 104(2):112-125. PubMed ID: 26910321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Method and timing of resection of superficial non-ampullary duodenal epithelial tumors.
    Kakushima N; Ono H; Takao T; Kanemoto H; Sasaki K
    Dig Endosc; 2014 Apr; 26 Suppl 2():35-40. PubMed ID: 24750146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.